Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Nusantara Sejahtera Raya Tbk.Trade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Nusantara Sejahtera Raya Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp95 (market cap 8T, 20.45M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 17× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 20.45M). Which is the better fit depends on your goals.

CNMAPRDL
Market Cap
8T470.58B
Volume
20.45M28.43M
Lot
204.52K284.34K
Turnover
1.97B7.8B
Average Price
96.33274.19
Value
1.97B7.8B
Indicative Equilibrium Price
95270
Indicative Equilibrium Volume
5.9K2.1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CNMA
View details
PRDL
View details

About Nusantara Sejahtera Raya Tbk.

PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.

Read more on CNMA

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL